During a median follow-up period of @ years , participants who were assigned to extended-release niacin-laropiprant had an LDL cholesterol level that was an average of @ mg per deciliter ( @ mmol per liter as measured in the central laboratory ) lower and an HDL cholesterol level that was an average of @ mg per deciliter ( @ mmol per liter ) higher than the levels in those assigned to placebo .